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Interleukin (IL)-12 is a heterodimeric glycoprotein of 70 kDa chronic hepatitis C, the goals of the therapeutic intervention are clearance of viremia and amelioration of the liver disease (p70) comprising two disulfide-bonded subunits with molecular masses of 40 kDa (p40 chain) and 35 kDa (p35 chain). [8] . In this work, we studied the serum IL-12 levels and the peripheral blood mononuclear cell (PBMC) production in a a cytokine produced by antigen-presenting cells in response to diverse stimuli, initiates cell-mediated immunity and promotes cohort of persons with persistent HCV infection. The relationships between the levels of IL-12 and host and virus factors predominance of T helper type 1 cells [1, 2] . Together with a secondary stimulus, interferon (IFN)-g influences specifically and IL-12 induction in relation to the therapeutic outcome following IFN-a treatment were investigated as well. the monocytic expression of IL-12 [3] . IL-12 can prevent or reduce mortality to lethal doses of the herpes simplex virus or the murine cytomegalovirus in mice; indeed, animals cured by IL-12 are immune to reinfection [2] . Also, IL-12 can prevent Materials and Methods or reverse retrovirus-induced immune deficiency. By enhancing ALT values but continued to have detectable HCV RNA, and 6 between patients and donors ( figure 1A). IFN-g with 100 ng/mL IFN-g (Promega, Madison, WI) for 16 h followed Serum IL-12 levels did not correlate with patient demoby LPS stimulation as above [3] . At the end of culture, supernatants graphic data (age: r s Å 0.14; time of known disease: r s Å .05),
were collected, centrifuged, filtered, aliquoted, and stored at 080ЊC
ALT values (r s Å 0.01), liver histology (r s Å 0.14), HCV until use.
Detection of IL-12.
To specifically detect the heterodimeric IL-RNA concentration (r s Å 0.14), and the HCV genotype 1b 12 p70, an ELISA was used as described previously [12] (reagents IL-12 (x 2 , 7.7; P Å .011). The score of liver fibrosis correlated with the IFN-g -induced IL-12 production (r s Å .348, P Å .005). Finally, histologic activity was independent of the proResults portion of monocytes (r s Å .03; P, NS). The baseline serum IL-12 levels ( figure 2A ) and the PBMC The serum levels of IL-12 were significantly higher in patients with chronic HCV infection than in healthy donors (mean production of the IFN-g/LPS-inducible IL-12 (figure 2B) were higher, although not statistically significant, in 5 of 16 patients IL-12 pg/mL { SE Å 946 { 235 vs. 595 { 284; P Å .004, Mann-Whitney test). IL-12 was produced spontaneously (mewith ALT normalization and loss of HCV RNA after IFN-a treatment compared with the remaining patients. At treatment dium alone) at low levels in PBMC cultures from 12 (18%) of 65 patients and 2 (8%) of 25 donors (P, not significant [NS]). cessation, however, serum IL-12 concentrations were significantly higher (P õ .05) in the 5 responder patients than in the Normally, LPS stimulation did not modify production of IL-12 compared with medium alone in patients (mean pg/mL { nonresponders who continued to have detectable HCV RNA, with either normal (n Å 5) or abnormal (n Å 6) ALT values SE Å 8.3 { 2.4 vs. 4.5 { 2.2; P, NS) and in donors (1.8 { 0.6 vs. 1.7 { 0.4; P, NS); there was no significant difference ( figure 2A decreased the PBMC production of the IFN-g/LPS-inducible to an immune defect of our patients, because it was also IL-12. At the end of therapy, IL-12 production by PBMC reobserved in donors. More likely, IL-12 p70 expression remained significantly (P õ .05) higher in responder patients quires specific triggering by IFN-g, together with a second-(end-of-treatment biochemical and virologic response) comary stimulus like LPS, as recently suggested [3] . In fact, pared with nonresponders (HCV RNA detectable, with normal LPS stimulation alone results in overproduction of only the or abnormal ALT values) (figure 2b).
IL-12 p40 chain, whereas formation of the p70 heterodimer requires coexpression of the p40 and p35 chains, the latter being specifically regulated by IFN-g priming [3] . AccordDiscussion ingly, IL-12 production increased significantly in patients and donors after IFN-g/LPS induction. However, HCV paIn this study, we investigated the serum concentrations tients produced significantly more IFN-g/LPS-inducible and the PBMC production of IL-12 in patients with chronic IL-12 than donors did, possibly due to the chronic inflam-HCV infection. Chronic hepatitis C patients had signifimatory process. This finding suggests that the ability of cantly higher serum levels of IL-12 than healthy donors.
PBMC to produce IL-12 in response to specific stimuli is IL-12 p70 is rapidly produced after infection; however, ILpreserved in patients with HCV infection, contrary to what 12 has a relatively long serum half-life compared with other has been reported in human immunodeficiency virus -incytokines, probably due to its higher molecular mass [1, fected patients, whose PBMC show an impaired IL-12 pro-2]. Thus, the likely explanation is that IL-12 accumulates duction associated with its immunodefiency [13] . A subset in serum following induction and release from the target of patients and donors did not produce IL-12, even with site of infection. Spontaneous secretion of detectable quantities of IL-12 was observed in PBMC from a minority of specific nonviral stimulatory signals. One explanation is patients and donors, and LPS stimulation failed to signifithat PBMC produce IL-12 at levels below the sensitivity of the assay. However, it cannot be ruled out that these cantly increase IL-12 production. The latter may not be due / 9d4a$$jy27 05-28-98 08:11:50 jinfas UC: J Infect cases may have a disturbed IL-12 inducibility. Monocytes, ing viral clearance from the infected cells [15] but may have a role in the immunopathogenesis of chronic hepatitis C as but also other cell types, might be defective in IL-12 production. This issue and the fact that HCV antigen -specific proinflammatory cytokine [1, 2] . Indeed, the IFN-g -primed IL-12 production correlated significantly with the liver necroinstimulation does not induce IL-12 production in infected individuals [14] are intriguing aspects deserving further flammatory activity, although not with ALT values, probably because serum ALT levels do not accurately reflect the level investigation.
In this study, we have not found any relationship between of inflammatory changes in chronic hepatitis C [8] . On the other hand, the association between IL-12 production and the serum levels or PBMC production of IL-12 and a patient's characteristics, the HCV genotype, or the viremia, suggesting liver fibrosis in our patients, although it suggests a possible involvement of IL-12 in the fibrogenic process, requires conthat IL-12 induction is not related to HCV replication. IL-12 is involved in the development of cellular responses determinfirmation.
